School based screening for tuberculosis infection in Norway: Comparison of positive tuberculin skin test with interferon-gamma release assay

BMC Infectious Diseases

Volumn 8, Issue , 2008, Pages

  Winje, Brita Askeland ^a   Oftung, Fredrik ^a   Korsvold, Gro Ellen ^a   Mannsåker, Turid ^a   Ly, Ingvild N ^b   Harstad, Ingunn ^c   Dyrhol Riise, Anne Margarita ^d   Heldal, Einar ^a  

^a NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^b ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^c NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^d HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; GAMMA INTERFERON; TUBERCULIN;

ADOLESCENT; ARTICLE; BCG VACCINATION; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEMOGRAPHY; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; NORWAY; PREVALENCE; PUBLIC HOSPITAL; QUESTIONNAIRE; RISK FACTOR; RURAL AREA; SENSITIVITY AND SPECIFICITY; SEROLOGY; TUBERCULIN TEST; TUBERCULOSIS; URBAN AREA; ANALYTICAL EQUIPMENT; BLOOD; CLINICAL TRIAL; COMPARATIVE STUDY; ISOLATION AND PURIFICATION; LABORATORY DIAGNOSIS; METHODOLOGY; MULTICENTER STUDY; MYCOBACTERIUM TUBERCULOSIS; REPRODUCIBILITY; STATISTICAL MODEL;

ADOLESCENT; CROSS-SECTIONAL STUDIES; DEMOGRAPHY; FALSE POSITIVE REACTIONS; FEMALE; HOSPITALS, PUBLIC; HUMANS; INTERFERON TYPE II; LOGISTIC MODELS; MALE; MASS SCREENING; MYCOBACTERIUM TUBERCULOSIS; NORWAY; PREVALENCE; REAGENT KITS, DIAGNOSTIC; REPRODUCIBILITY OF RESULTS; RISK FACTORS; SENSITIVITY AND SPECIFICITY; TUBERCULIN TEST; TUBERCULOSIS;

EID: 56049112126     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-8-140     Document Type: Article

References (33)

1. Winje BA Mannsåker T Heldal E Dahle UR Tuberkulose i Norge 2006 (Norwegian only) MSIS-rapport 2007:35
2. Folkehelseinstituttet Forebygging og kontroll av tuberkulose: En veileder (Guidelines for prevention and control of tuberculosis, Norwegian only) Oslo: Folkehelseinstituttet 7 2002
3. Dahle UR Sandven P Heldal E Caugant DA Continued low rates of transmission of Mycobacterium tuberculosis in Norway J Clin Microbiol 2003, 41:2968-2973 165220 12843028 10.1128/JCM.41.7.2968-2973.2003
4. Dahle UR Eldholm V Winje BA Mannsaker T Heldal E Impact of immigration on the molecular epidemiology of Mycobacterium tuberculosis in a low-incidence country Am J Respir Crit Care Med 2007, 176:930-935 10.1164/rccm.200702-187OC 17673698
5. Andersen P Munk ME Pollock JM Doherty TM Specific immune-based diagnosis of tuberculosis Lancet 2000, 356:1099-1104 10.1016/S0140-6736(00)02742-2 11009160
6. Pai M Riley LW Colford JM Jr Interferon-gamma assays in the immunodiagnosis of tuberculosis: A systematic review Lancet Infect Dis 2004, 4:761-776 10.1016/S1473-3099(04)01206-X 15567126
7. Arend SM Thijsen SF Leyten EM Bouwman JJ Franken WP Koster BF et al. Comparison of two interferon-gamma assays and tuberculin skin test for tracing tuberculosis contacts Am J Respir Crit Care Med 2007, 175:618-627 10.1164/rccm.200608-1099OC 17170386
8. Brock I Weldingh K Lillebaek T Follmann F Andersen P Comparison of tuberculin skin test and new specific blood test in tuberculosis contacts Am J Respir Crit Care Med 2004, 170:65-69 10.1164/ rccm.200402-232OC 15087297
9. Ewer K Deeks J Alvarez L Bryant G Waller S Andersen P et al. Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak Lancet 2003, 361:1168-1173 10.1016/S0140-6736(03)12950-9 12686038
10. Lalvani A Pathan AA Durkan H Wilkinson KA Whelan A Deeks JJ et al. Enhanced contact tracing and spatial tracking of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells Lancet 2001, 357:2017-2021 10.1016/S0140-6736(00)05115-1 11438135
11. Hill PC Brookes RH Adetifa IM Fox A Jackson-Sillah D Lugos MD et al. Comparison of enzyme-linked immunospot assay and tuberculin skin test in healthy children exposed to Mycobacterium tuberculosis Pediatrics 2006, 117:1542-1548 10.1542/peds.2005-2095 16651307
12. Pai M Kalantri S Dheda K New tools and emerging technologies for the diagnosis of tuberculosis: Part I. Latent tuberculosis Expert Rev Mol Diagn 2006, 6:413-422 10.1586/14737159.6.3.413 16706743
13. Comstock GW Edwards LB Philip RN Winn WA A comparison in the United States of America of two tuberculins, PPD-S and RT23 Bull World Health Organ 1964, 31:161-170 14253239
14. Mori T Sakatani M Yamagishi F Takashima T Kawabe Y Nagao K et al. Specific detection of tuberculosis infection: An interferon-gamma-based assay using new antigens Am J Respir Crit Care Med 2004, 170:59-64 10.1164/rccm.200402-179OC 15059788
15. Bahrmand AR Madani H Samar G Khalilzadeh L Bakayev VV Yaghli M et al. Detection and identification of non-tuberculous mycobacterial infections in 6,472 tuberculosis suspected patients Scand J Infect Dis 1996, 28:275-278 10.3109/00365549609027172 8863361
16. Berkel GM Cobelens FG de Vries G Draayer-Jansen IW Borgdorff MW Tuberculin skin test: Estimation of positive and negative predictive values from routine data Int J Tuberc Lung Dis 2005, 9:310-316 15786896
17. von Reyn CF Horsburgh CR Olivier KN Barnes PF Waddell R Warren C et al. Skin test reactions to Mycobacterium tuberculosis purified protein derivative and Mycobacterium avium sensitin among health care workers and medical students in the United States Int J Tuberc Lung Dis 2001, 5:1122-1128 11769770
18. Farhat M Greenaway C Pai M Menzies D False-positive tuberculin skin tests: What is the absolute effect of BCG and non-tuberculous mycobacteria? Int J Tuberc Lung Dis 2006, 10:1192-1204 17131776
19. Diel R Ernst M Doscher G Visuri-Karbe L Greinert U Niemann S et al. Avoiding the effect of BCG vaccination in detecting Mycobacterium tuberculosis infection with a blood test Eur Respir J 2006, 28:16-23 10.1183/09031936.06.00107005 16481383
20. Hill PC Brookes RH Fox A Fielding K Jeffries DJ Jackson-Sillah D et al. Large-scale evaluation of enzyme-linked immunospot assay and skin test for diagnosis of Mycobacterium tuberculosis infection against a gradient of exposure in The Gambia Clin Infect Dis 2004, 38:966-973 10.1086/ 382362 15034828
21. Lalvani A Richeldi L Kunst H Interferon gamma assays for tuberculosis Lancet Infect Dis 2005, 5:322-324 10.1016/S1473-3099(05)70118-3 15919613
22. Mazurek GH Jereb J Lobue P Iademarco MF Metchock B Vernon A Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States MMWR Recomm Rep 2005, 54:49-55 16357824
23. Franken WP Timmermans JF Prins C Slootman EJ Dreverman J Bruins H et al. Comparison of Mantoux and QuantiFERON TB Gold tests for diagnosis of latent tuberculosis infection in Army personnel Clin Vaccine Immunol 2007, 14:477-480 1865601 17301213 10.1128/CVI.00463-06
24. Mahomed H Hughes EJ Hawkridge T Minnies D Simon E Little F Comparison of mantoux skin test with three generations of a whole blood IFN-gamma assay for tuberculosis infection Int J Tuberc Lung Dis 2006, 10:310-316 16562712
25. Leyten EM Arend SM Prins C Cobelens FG Ottenhoff TH van Dissel JT Discrepancy between Mycobacterium tuberculosis-specific gamma interferon release assays using short and prolonged in vitro incubation Clin Vaccine Immunol 2007, 14:880-885 1951056 17507543 10.1128/CVI.00132-07
26. Arend SM van Meijgaarden KE de Boer K de Palou EC van Soolingen D Ottenhoff TH et al. Tuberculin skin testing and in vitro T cell responses to ESAT-6 and culture filtrate protein 10 after infection with Mycobacterium marinum or M. kansasii J Infect Dis 2002, 186:1797-1807 10.1086/345760 12447766
27. Leyten EM Prins C Bossink AW Thijsen S Ottenhoff TH van Dissel JT Effect of tuberculin skin testing on a Mycobacterium tuberculosis-specific IFN-{gamma} assay Eur Respir J 2007, 29:1212-1216 10.1183/ 09031936.00117506 17215314
28. Drobniewski F Cobelens F Zellweger J-P Use of Gamma-interferon assays in low- and medium-prevalence countries in Europe: A consensus statement of a Wolfheze Workshop organised by KNCV/EuroTB, Vilnius Sept 2006 Euro Surveill 2007, 12:7 E070726.2 17868554
29. Zellweger JP Zellweger A Ansermet S de Senarclens B Wrighton-Smith P Contact tracing using a new T-cell-based test: Better correlation with tuberculosis exposure than the tuberculin skin test Int J Tuberc Lung Dis 2005, 9:1242-1247 16333932
30. Comstock GW Livesay VT Woolpert SF The prognosis of a positive tuberculin reaction in childhood and adolescence Am J Epidemiol 1974, 99:131-138 4810628
31. Perry S Sanchez L Yang S Agarwal Z Hurst P Parsonnet J Reproducibility of QuantiFERON-TB gold in-tube assay Clin Vaccine Immunol 2008, 15:425-432 2268272 18199741 10.1128/CVI.00398-07
32. Veerapathran A Joshi R Goswami K Dogra S Moodie EE Reddy MV et al. T-cell assays for tuberculosis infection: Deriving cut-offs for conversions using reproducibility data PLoS ONE 2008, 3:e1850 2266993 18365006 10.1371/journal.pone.0001850
33. Winje BA Oftung F Korsvold GE Mannsaker T Jeppesen AS et al. Harstad I Screening for tuberculosis infection among newly arrived asylum seekers: comparison of QuantiFERON(R)TB Gold with tuberculin skin test BMC Infect Dis 2008, 8:65 2405787 18479508 10.1186/1471-2334-8-65